Clinical Trial Update: Corneal Endothelial Cell Loss in Diabetes Type II During Cataract Surgery

View source ↗

Summary

The clinical trial evaluating corneal endothelial cell loss during cataract surgery in patients with Type 2 diabetes has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Frederiksberg University Hospital | Conditions: Diabetes Mellitus | Status: SUSPENDED